IPO News | AnnoRoad's Hong Kong IPO Prospectus Expires

Stock News

Sep 25

AnnoRoad Gene Technology (Beijing) Co., Ltd. (AnnoRoad) saw its Hong Kong IPO prospectus expire on September 25th, six months after its submission on March 25th. China Construction Bank International and Guotai Junan International served as joint sponsors for the listing.

According to the prospectus, AnnoRoad is a company focused on IVD medical devices and multi-omics life science research services based on molecular diagnostics, and is also an industry pioneer specializing in NGS-based prenatal testing IVD products. The company's clinical sequencing solutions include self-produced gene sequencing-based IVD testing kits, gene sequencers and bioinformatics analysis software, as well as supporting technical support and laboratory design services.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1170188000"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1170188000\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1170188000?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-25 06:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170188000","market":"hk","top_or_hot":-1,"title":"IPO News | AnnoRoad's Hong Kong IPO Prospectus Expires","media":"Stock News","content":"<p>AnnoRoad Gene Technology (Beijing) Co., Ltd. (AnnoRoad) saw its Hong Kong IPO prospectus expire on September 25th, six months after its submission on March 25th. China Construction Bank International and Guotai Junan International served as joint sponsors for the listing.</p>\n<p>According to the prospectus, AnnoRoad is a company focused on IVD medical devices and multi-omics life science research services based on molecular diagnostics, and is also an industry pioneer specializing in NGS-based prenatal testing IVD products. The company's clinical sequencing solutions include self-produced gene sequencing-based IVD testing kits, gene sequencers and bioinformatics analysis software, as well as supporting technical support and laboratory design services.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IPO News | AnnoRoad's Hong Kong IPO Prospectus Expires</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIPO News | AnnoRoad's Hong Kong IPO Prospectus Expires\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-09-25 06:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>AnnoRoad Gene Technology (Beijing) Co., Ltd. (AnnoRoad) saw its Hong Kong IPO prospectus expire on September 25th, six months after its submission on March 25th. China Construction Bank International and Guotai Junan International served as joint sponsors for the listing.</p>\n<p>According to the prospectus, AnnoRoad is a company focused on IVD medical devices and multi-omics life science research services based on molecular diagnostics, and is also an industry pioneer specializing in NGS-based prenatal testing IVD products. The company's clinical sequencing solutions include self-produced gene sequencing-based IVD testing kits, gene sequencers and bioinformatics analysis software, as well as supporting technical support and laboratory design services.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HSTECH","symbol_name":"恒生科技指数","start_time":0,"source_url":"","article_id":"1170188000","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170188000","pubTimestamp":1758753496,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"AnnoRoad Gene Technology (Beijing) Co., Ltd. (AnnoRoad) saw its Hong Kong IPO prospectus expire on September 25th, six months after its submission on March 25th. China Construction Bank International...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HSTECH":"恒生科技指数","07226":"南方两倍做多恒科","YANG":"三倍做空富时中国ETF-Direxion","HSCEI":"国企指数","BK4614":"Manus概念股"},"translate_title":"IPO快讯|安诺路香港IPO招股书失效","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"07226":1,"HSCEI":1,"HSTECH":1,"YANG":1},"content_text":"AnnoRoad Gene Technology (Beijing) Co., Ltd. (AnnoRoad) saw its Hong Kong IPO prospectus expire on September 25th, six months after its submission on March 25th. China Construction Bank International and Guotai Junan International served as joint sponsors for the listing.\nAccording to the prospectus, AnnoRoad is a company focused on IVD medical devices and multi-omics life science research services based on molecular diagnostics, and is also an industry pioneer specializing in NGS-based prenatal testing IVD products. The company's clinical sequencing solutions include self-produced gene sequencing-based IVD testing kits, gene sequencers and bioinformatics analysis software, as well as supporting technical support and laboratory design services.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}